Opioids as agents of reward-related feeding: a consideration of the evidence

Physiology & Behavior
Allen S Levine, Charles J Billington

Abstract

Gerard Smith was one of the pioneers in the field of neuropeptidergic control of food intake. He established methodology and criteria used to determine whether a neuropeptide acts as an endogenous satiety factor. More recently, he theorized that there are direct and indirect controls of meal size. Direct controls include those that depend upon contact of food with preabsorptive receptors from the tip of the tongue to the end of the small intestine, and indirect controls include those that do not depend upon direct contact of mucosal receptors, such as learning and metabolism. In this review, we consider the evidence that opioids are mediators of reward-related feeding. We address these issues adopting Smith's approach to problem solving, including an evaluation of the opioids as controllers of the meal. We also present a novel concept of "hedonic restriction," resulting in a change in opioid gene expression. Overall, we believe the evidence supporting opioid participation in reward-driven and other types of ingestion is very strong, but much work remains before we understand how opioids contribute to the widely distributed neural network that controls ingestive behavior.

References

Nov 1, 1991·Physiology & Behavior·D J Shide, E M Blass
Jan 1, 1991·Psychopharmacology·J W Spain, G C Newsom
Oct 1, 1990·Pharmacology, Biochemistry, and Behavior·B A GosnellM J Majchrzak
Jul 1, 1990·Pharmacology, Biochemistry, and Behavior·T CanliK A Miczek
Mar 1, 1988·Peptides·D L TempelS F Leibowitz
Jan 12, 1988·Brain Research·R YirmiyaJ C Liebeskind
Apr 1, 1986·Pharmacology, Biochemistry, and Behavior·W C Lynch
Jan 1, 1987·Neuroscience and Biobehavioral Reviews·A SclafaniM Vigorito
Sep 1, 1973·Journal of Comparative and Physiological Psychology·J GibbsG P Smith
May 1, 1980·Pharmacology, Biochemistry, and Behavior·J Le MagnenM Devos
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·R Marks-KaufmanE Gross
Jan 1, 1982·Physiology & Behavior·A S LevineJ E Morley
Dec 1, 1982·Physiology & Behavior·G A Rockwood, L D Reid
Oct 1, 1994·Pharmacology, Biochemistry, and Behavior·J M RudskiA S Levine
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·G P Smith
Nov 1, 1996·Alcoholism, Clinical and Experimental Research·L D ReidC L Hubbell
Nov 5, 1999·Pharmacology, Biochemistry, and Behavior·W Z YuR J Bodnar
Apr 15, 2000·Pharmacology, Biochemistry, and Behavior·A R DelamaterR J Bodnar
Jun 11, 2002·Obesity Research·Carlo ColantuoniBartley G Hoebel
Oct 12, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Allen S LevineCharles J Billington

❮ Previous
Next ❯

Citations

Oct 13, 2006·Psychopharmacology·M Flavia Barbano, Martine Cador
Jul 30, 2008·The Behavioral and Brain Sciences·A David RedishAdam Johnson
Nov 23, 2005·Behavioral Neuroscience·Mary M BoggianoPamela K Wauford
Jan 13, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N R LenardH-R Berthoud
Apr 15, 2008·Annual Review of Nutrition·Mary-Ellen HarperMartin D Brand
Dec 25, 2007·Annual Review of Psychology·Hans-Rudolf Berthoud, Christopher Morrison
Jun 24, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Nicole R Kinzeler, Susan P Travers
Dec 6, 2008·The American Journal of Clinical Nutrition·Richard D Mattes, Barry M Popkin
May 5, 2011·Physiology & Behavior·Nicholas T BelloTimothy H Moran
Jun 29, 2010·Pharmacology, Biochemistry, and Behavior·Susana Peciña, Kyle S Smith
Mar 10, 2010·Physiology & Behavior·Sharif A Taha
Jan 13, 2009·Physiology & Behavior·Tiffany R BeckmanCharles J Billington
Jun 3, 2008·Physiology & Behavior·Susana Peciña
May 7, 2008·Neuroscience and Biobehavioral Reviews·Pawel K OlszewskiHelgi B Schiöth
Dec 25, 2007·Physiology & Behavior·Angela S Guarda
Jul 10, 2007·Neuroscience and Biobehavioral Reviews·Nicole M AvenaBartley G Hoebel
Jun 5, 2007·Physiology & Behavior·Tanja C Adam, Elissa S Epel
Feb 24, 2007·Physiology & Behavior·Pawel K Olszewski, Allen S Levine
May 18, 2005·Alcoholism, Clinical and Experimental Research·Krisztina M KovacsCsaba Vadasz
Jun 28, 2007·Annals of the New York Academy of Sciences·A David Redish, Adam Johnson
Mar 24, 2006·The European Journal of Neuroscience·Heather G WardKenny J Simansky
Mar 6, 2010·Annals of the New York Academy of Sciences·Joseph FrascellaAnna Rose Childress
Apr 15, 2010·Brain Research·Kent C BerridgeAlexandra G DiFeliceantonio
Mar 17, 2006·Pharmacology, Biochemistry, and Behavior·Patricia A JaroszDonald V Coscina
Dec 21, 2005·Brain Research Reviews·Daniela CotaAllen S Levine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.